Tesamorelin 12 mg vial

A peptide option used in clinician-guided programs focused on visceral-fat and body-composition goals. Estimated supply may range from approximately 1–6 weeks depending on the prescribed dose. Compounded tesamorelin should not be represented as interchangeable with branded formulations. Supply duration is dose-dependent and varies with the prescribed dose, frequency, concentration, pharmacy instructions, and beyond-use date. Each program includes a telehealth visit with a medical provider who may prescribe treatment if the patient is eligible; direct-to-patient pharmacy shipping; secure messaging with the medical provider regarding side effects and dosage; and convenient refill coordination. Treatment plans are based on the medical provider’s clinical judgment, and results vary from patient to patient.